Clinical Trial Detail

NCT ID NCT02989064
Title MAGE-A10c796T for Urothelial Cancer, Melanoma or Head and Neck Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Adaptimmune
Indications

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

melanoma

head and neck squamous cell carcinoma

Therapies
Age Groups: adult senior

No variant requirements are available.